Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ARQT

Updated 10/6/2026, 6:18 PM ET.

ARQT

Arcutis Biotherapeutics, Inc.

Sale$91,853

Matsuda Masaru

See Remarks

3,674 shat $25.00Filed Sep 18, 4:17 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$114,371

Welgus Howard G.

Director

4,730 shat $24.18Filed Sep 17, 4:06 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$249,986

Matsuda Masaru

See Remarks

9,989 shat $25.03Filed Sep 10, 7:24 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$956,123

Curran Terrie

Director

38,200 shat $25.03Filed Aug 28, 5:40 PM ETFiling
ARQT

Arcutis Biotherapeutics, Inc.

Sale$27,912

Curran Terrie

Director

1,072 shat $26.04Filed Aug 24, 4:19 PM ETFiling
ARQT

Arcutis Biotherapeutics, Inc.

Sale$45,819

Burnett Patrick

See Remarks

1,697 shat $27.00Filed Aug 21, 4:08 PM ETFiling
ARQT

Arcutis Biotherapeutics, Inc.

Sale$123,835

Welgus Howard G.

Director

4,730 shat $26.18Filed Aug 19, 4:57 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$394,897

Burnett Patrick

See Remarks

15,000 shat $26.33Filed Aug 13, 8:06 PM ETFiling
ARQT

Arcutis Biotherapeutics, Inc.

Sale$24,942

Burnett Patrick

See Remarks

955 shat $26.12Filed Aug 5, 9:42 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$32,124

Matsuda Masaru

See Remarks

1,230 shat $26.12Filed Aug 5, 9:42 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$114,261

Watanabe Todd

See Remarks, Director

4,375 shat $26.12Filed Aug 5, 9:42 PM ET
Filing
ARQT

Arcutis Biotherapeutics, Inc.

Sale$127,284

Welgus Howard G.

Director

4,730 shat $26.91Filed Jul 17, 4:01 PM ET
Filing

Read from public SEC filings. Not financial advice.